Skip to main content

Methylphenidate Hydrochloride Tablet, Extended Release Shortage

Last Updated: September 16, 2025
Status: Current

Unavailable, Current:

Limited Availability, Current:

Available, Current:

Methylphenidate Hydrochloride, Tablet, Extended Release, 18 mg (Dr. Reddy's Laboratories, Inc.)

NDC Code: 43598-438-01
Availability: Unavailable
Status: Current
Date of update: September 16, 2025
Update type: Reverified
Reason for shortage: Other
Related Information: Estimated availability TBD
Therapeutic category: Psychiatry
Initial posting date: July 26, 2023
Contact info: 866-732-3952

Methylphenidate Hydrochloride, Tablet, Extended Release, 18 mg (Sun Pharmaceutical Industries, Inc.)

NDC Code: 57664-606-88
Availability: Unavailable
Status: Current
Date of update: September 5, 2025
Update type: Revised
Reason for shortage: Discontinuation of the manufacture of the drug
Related Information: Currently not marketed
Therapeutic category: Psychiatry
Initial posting date: July 26, 2023
Contact info: 800-818-4555

Methylphenidate Hydrochloride, Tablet, Extended Release, 27 mg (SpecGx LLC)

NDC Code: 0406-0127-01
Availability: Unavailable
Status: Current
Date of update: September 15, 2025
Update type: Reverified
Reason for shortage: Shortage of an active ingredient
Related Information: Backorder expected with next release expected in October 2025.
Therapeutic category: Psychiatry
Initial posting date: July 26, 2023
Contact info: 800-325-8888

Methylphenidate Hydrochloride, Tablet, Extended Release, 27 mg (Lannett Company, Inc.)

NDC Code: 62175-311-37
Availability: Unavailable
Status: Current
Date of update: September 15, 2025
Update type: Revised
Reason for shortage: Shortage of an active ingredient
Related Information: Unavailable
Therapeutic category: Psychiatry
Initial posting date: July 26, 2023
Contact info: 844-834-0530

Methylphenidate Hydrochloride, Tablet, Extended Release, 27 mg (Dr. Reddy's Laboratories, Inc.)

NDC Code: 43598-439-01
Availability: Unavailable
Status: Current
Date of update: September 16, 2025
Update type: Reverified
Reason for shortage: Other
Related Information: Estimated availability TBD
Therapeutic category: Psychiatry
Initial posting date: July 26, 2023
Contact info: 866-732-3952

Methylphenidate Hydrochloride, Tablet, Extended Release, 27 mg (Sun Pharmaceutical Industries, Inc.)

NDC Code: 57664-607-88
Availability: Unavailable
Status: Current
Date of update: September 5, 2025
Update type: Revised
Reason for shortage: Discontinuation of the manufacture of the drug
Related Information: Currently not marketed
Therapeutic category: Psychiatry
Initial posting date: July 26, 2023
Contact info: 800-818-4555

Methylphenidate Hydrochloride, Tablet, Extended Release, 36 mg (Lannett Company, Inc.)

NDC Code: 62175-312-37
Availability: Unavailable
Status: Current
Date of update: September 15, 2025
Update type: Revised
Reason for shortage: Shortage of an active ingredient
Related Information: Unavailable
Therapeutic category: Psychiatry
Initial posting date: July 26, 2023
Contact info: 844-834-0530

Methylphenidate Hydrochloride, Tablet, Extended Release, 36 mg (Sun Pharmaceutical Industries, Inc.)

NDC Code: 57664-608-88
Availability: Unavailable
Status: Current
Date of update: September 5, 2025
Update type: Revised
Reason for shortage: Discontinuation of the manufacture of the drug
Related Information: Currently not marketed
Therapeutic category: Psychiatry
Initial posting date: July 26, 2023
Contact info: 800-818-4555

Methylphenidate Hydrochloride, Tablet, Extended Release, 54 mg (SpecGx LLC)

NDC Code: 0406-0154-01
Availability: Unavailable
Status: Current
Date of update: September 15, 2025
Update type: Reverified
Reason for shortage: Shortage of an active ingredient
Related Information: Backorder. Next release expected in October 2025.
Therapeutic category: Psychiatry
Initial posting date: July 26, 2023
Contact info: 800-325-8888

Methylphenidate Hydrochloride, Tablet, Extended Release, 54 mg (Dr. Reddy's Laboratories, Inc.)

NDC Code: 43598-441-01
Availability: Unavailable
Status: Current
Date of update: September 16, 2025
Update type: Reverified
Reason for shortage: Other
Related Information: Estimated availability TBD
Therapeutic category: Psychiatry
Initial posting date: July 26, 2023
Contact info: 866-732-3952

Methylphenidate Hydrochloride, Tablet, Extended Release, 54 mg (Sun Pharmaceutical Industries, Inc.)

NDC Code: 57664-609-88
Availability: Unavailable
Status: Current
Date of update: September 5, 2025
Update type: Revised
Reason for shortage: Discontinuation of the manufacture of the drug
Related Information: Currently not marketed
Therapeutic category: Psychiatry
Initial posting date: July 26, 2023
Contact info: 800-818-4555

Relexxii, Tablet, Extended Release, 18 mg (Vertical Pharmaceuticals, LLC)

NDC Code: 68025-095-10
Availability: Unavailable
Status: Current
Date of update: September 4, 2025
Update type: Reverified
Reason for shortage: Other
Related Information: Estimated recovery: TBD
Therapeutic category: Psychiatry
Initial posting date: July 26, 2023
Contact info: 800-541-4802

Relexxii, Tablet, Extended Release, 27 mg (Vertical Pharmaceuticals, LLC)

NDC Code: 68025-096-10
Availability: Unavailable
Status: Current
Date of update: September 4, 2025
Update type: Reverified
Reason for shortage: Other
Related Information: Estimated recovery: TBD
Therapeutic category: Psychiatry
Initial posting date: July 26, 2023
Contact info: 800-541-4802

Relexxii, Tablet, Extended Release, 36 mg (Vertical Pharmaceuticals, LLC)

NDC Code: 68025-097-10
Availability: Unavailable
Status: Current
Date of update: September 4, 2025
Update type: Reverified
Reason for shortage: Other
Related Information: Estimated recovery: TBD
Therapeutic category: Psychiatry
Initial posting date: July 26, 2023
Contact info: 800-541-4802

Relexxii, Tablet, Extended Release, 54 mg (Vertical Pharmaceuticals, LLC)

NDC Code: 68025-098-10
Availability: Unavailable
Status: Current
Date of update: September 4, 2025
Update type: Reverified
Reason for shortage: Other
Related Information: Estimated recovery: TBD
Therapeutic category: Psychiatry
Initial posting date: July 26, 2023
Contact info: 800-541-4802

Methylin Er, Tablet, Extended Release, 10 mg (SpecGx LLC)

NDC Code: 0406-1445-01
Availability: Limited Availability
Status: Current
Date of update: September 15, 2025
Update type: Reverified
Reason for shortage: Shortage of an active ingredient
Related Information: Allocation to all customers.
Therapeutic category: Psychiatry
Initial posting date: July 26, 2023
Contact info: 800-325-8888

Methylin Er, Tablet, Extended Release, 20 mg (SpecGx LLC)

NDC Code: 0406-1473-01
Availability: Limited Availability
Status: Current
Date of update: September 15, 2025
Update type: Reverified
Reason for shortage: Shortage of an active ingredient
Related Information: Allocation to all customers. Short term backorder expected in September with recovery in October 2025.
Therapeutic category: Psychiatry
Initial posting date: July 26, 2023
Contact info: 800-325-8888

Methylphenidate Hydrochloride Extended-Release Tablets, USP CII, Tablet, Extended Release, 54 mg (Teva Pharmaceuticals USA, Inc.)

NDC Code: 62037-727-01
Availability: Limited Availability
Status: Current
Date of update: September 15, 2025
Update type: Revised
Reason for shortage: Demand increase for the drug
Related Information: Limited Availability
Therapeutic category: Psychiatry
Initial posting date: July 26, 2023
Contact info: 800-545-8800

Methylphenidate Hydrochloride, Tablet, Extended Release, 18 mg (Trigen Laboratories, LLC)

NDC Code: 13811-706-10
Availability: Limited Availability
Status: Current
Date of update: September 4, 2025
Update type: Reverified
Reason for shortage: Demand increase for the drug
Related Information: Allocation to current contracted customers
Therapeutic category: Psychiatry
Initial posting date: July 26, 2023
Contact info: 800-541-4802

Methylphenidate Hydrochloride, Tablet, Extended Release, 27 mg (Trigen Laboratories, LLC)

NDC Code: 13811-707-10
Availability: Limited Availability
Status: Current
Date of update: September 4, 2025
Update type: Reverified
Reason for shortage: Demand increase for the drug
Related Information: Allocation to current contracted customers
Therapeutic category: Psychiatry
Initial posting date: July 26, 2023
Contact info: 800-541-4802

Methylphenidate Hydrochloride, Tablet, Extended Release, 36 mg (SpecGx LLC)

NDC Code: 0406-0136-01
Availability: Limited Availability
Status: Current
Date of update: September 15, 2025
Update type: Reverified
Reason for shortage: Shortage of an active ingredient
Related Information: Allocation to all customers. Short term backorder expected in September with recovery in October 2025.
Therapeutic category: Psychiatry
Initial posting date: July 26, 2023
Contact info: 800-325-8888

Methylphenidate Hydrochloride, Tablet, Extended Release, 36 mg (Trigen Laboratories, LLC)

NDC Code: 13811-708-10
Availability: Limited Availability
Status: Current
Date of update: September 4, 2025
Update type: Reverified
Reason for shortage: Demand increase for the drug
Related Information: Allocation to current contracted customers
Therapeutic category: Psychiatry
Initial posting date: July 26, 2023
Contact info: 800-541-4802

Methylphenidate Hydrochloride, Tablet, Extended Release, 45 mg (Trigen Laboratories, LLC)

NDC Code: 13811-711-30
Availability: Limited Availability
Status: Current
Date of update: September 4, 2025
Update type: Reverified
Reason for shortage: Demand increase for the drug
Related Information: Allocation to current contracted customers
Therapeutic category: Psychiatry
Initial posting date: July 26, 2023
Contact info: 800-541-4802

Methylphenidate Hydrochloride, Tablet, Extended Release, 54 mg (Trigen Laboratories, LLC)

NDC Code: 13811-709-10
Availability: Limited Availability
Status: Current
Date of update: September 4, 2025
Update type: Reverified
Reason for shortage: Demand increase for the drug
Related Information: Allocation to current contracted customers
Therapeutic category: Psychiatry
Initial posting date: July 26, 2023
Contact info: 800-541-4802

Methylphenidate Hydrochloride, Tablet, Extended Release, 63 mg (Trigen Laboratories, LLC)

NDC Code: 13811-700-30
Availability: Limited Availability
Status: Current
Date of update: September 4, 2025
Update type: Reverified
Reason for shortage: Demand increase for the drug
Related Information: Allocation to current contracted customers
Therapeutic category: Psychiatry
Initial posting date: July 26, 2023
Contact info: 800-541-4802

Methylphenidate Hydrochloride, Tablet, Extended Release, 72 mg (Trigen Laboratories, LLC)

NDC Code: 13811-710-30
Availability: Limited Availability
Status: Current
Date of update: September 4, 2025
Update type: Reverified
Reason for shortage: Demand increase for the drug
Related Information: Allocation to current contracted customers
Therapeutic category: Psychiatry
Initial posting date: July 26, 2023
Contact info: 800-541-4802

Concerta, Tablet, Extended Release, 18 mg (Janssen Pharmaceuticals)

NDC Code: 50458-585-01
Availability: Available
Status: Current
Date of update: September 15, 2025
Update type: Reverified
Therapeutic category: Psychiatry
Initial posting date: July 26, 2023
Contact info: 800-JANSSEN (1-800-526-7736) Monday through Friday from 9:00 AM to 8:00 PM ET

Concerta, Tablet, Extended Release, 27 mg (Janssen Pharmaceuticals)

NDC Code: 50458-588-01
Availability: Available
Status: Current
Date of update: September 15, 2025
Update type: Reverified
Therapeutic category: Psychiatry
Initial posting date: July 26, 2023
Contact info: 800-JANSSEN (1-800-526-7736) Monday through Friday from 9:00 AM to 8:00 PM ET

Concerta, Tablet, Extended Release, 36 mg (Janssen Pharmaceuticals)

NDC Code: 50458-586-01
Availability: Available
Status: Current
Date of update: September 15, 2025
Update type: Reverified
Therapeutic category: Psychiatry
Initial posting date: July 26, 2023
Contact info: 800-JANSSEN (1-800-526-7736) Monday through Friday from 9:00 AM to 8:00 PM ET

Concerta, Tablet, Extended Release, 54 mg (Janssen Pharmaceuticals)

NDC Code: 50458-587-01
Availability: Available
Status: Current
Date of update: September 15, 2025
Update type: Reverified
Therapeutic category: Psychiatry
Initial posting date: July 26, 2023
Contact info: 800-JANSSEN (1-800-526-7736) Monday through Friday from 9:00 AM to 8:00 PM ET

Methylphenidate Hydrochloride Extended-Release Tablets, USP CII, Tablet, Extended Release, 18 mg (Teva Pharmaceuticals USA, Inc.)

NDC Code: 62037-725-01
Availability: Available
Status: Current
Date of update: September 15, 2025
Update type: Revised
Therapeutic category: Psychiatry
Initial posting date: July 26, 2023
Contact info: 800-545-8800

Methylphenidate Hydrochloride Extended-Release Tablets, USP CII, Tablet, Extended Release, 27 mg (Teva Pharmaceuticals USA, Inc.)

NDC Code: 62037-734-01
Availability: Available
Status: Current
Date of update: September 15, 2025
Update type: Revised
Therapeutic category: Psychiatry
Initial posting date: July 26, 2023
Contact info: 800-545-8800

Methylphenidate Hydrochloride Extended-Release Tablets, USP CII, Tablet, Extended Release, 36 mg (Teva Pharmaceuticals USA, Inc.)

NDC Code: 62037-726-01
Availability: Available
Status: Current
Date of update: September 15, 2025
Update type: Revised
Therapeutic category: Psychiatry
Initial posting date: July 26, 2023
Contact info: 800-545-8800

Methylphenidate Hydrochloride, Tablet, Extended Release, 18 mg (Lannett Company, Inc.)

NDC Code: 62175-310-37
Availability: Available
Status: Current
Date of update: September 15, 2025
Update type: Revised
Reason for shortage: Shortage of an active ingredient
Related Information: Limited Availability
Therapeutic category: Psychiatry
Initial posting date: July 26, 2023
Contact info: 844-834-0530

Methylphenidate Hydrochloride, Tablet, Extended Release, 36 mg (Dr. Reddy's Laboratories, Inc.)

NDC Code: 43598-440-01
Availability: Available
Status: Current
Date of update: September 16, 2025
Update type: Reverified
Related Information: Available to existing customers
Therapeutic category: Psychiatry
Initial posting date: July 26, 2023
Contact info: 866-732-3952

Methylphenidate Hydrochloride, Tablet, Extended Release, 54 mg (Lannett Company, Inc.)

NDC Code: 62175-313-37
Availability: Available
Status: Current
Date of update: September 15, 2025
Update type: Revised
Reason for shortage: Shortage of an active ingredient
Related Information: Limited Availability
Therapeutic category: Psychiatry
Initial posting date: July 26, 2023
Contact info: 844-834-0530

Relexxii, Tablet, Extended Release, 18 mg (Vertical Pharmaceuticals, LLC)

NDC Code: 68025-095-30
Availability: Available
Status: Current
Date of update: September 4, 2025
Update type: Reverified
Therapeutic category: Psychiatry
Initial posting date: July 26, 2023
Contact info: 800-541-4802

Relexxii, Tablet, Extended Release, 27 mg (Vertical Pharmaceuticals, LLC)

NDC Code: 68025-096-30
Availability: Available
Status: Current
Date of update: September 4, 2025
Update type: Reverified
Therapeutic category: Psychiatry
Initial posting date: July 26, 2023
Contact info: 800-541-4802

Relexxii, Tablet, Extended Release, 36 mg (Vertical Pharmaceuticals, LLC)

NDC Code: 68025-097-30
Availability: Available
Status: Current
Date of update: September 4, 2025
Update type: Reverified
Therapeutic category: Psychiatry
Initial posting date: July 26, 2023
Contact info: 800-541-4802

Relexxii, Tablet, Extended Release, 45 mg (Vertical Pharmaceuticals, LLC)

NDC Code: 68025-088-30
Availability: Available
Status: Current
Date of update: September 4, 2025
Update type: Reverified
Therapeutic category: Psychiatry
Initial posting date: July 26, 2023
Contact info: 800-541-4802

Relexxii, Tablet, Extended Release, 54 mg (Vertical Pharmaceuticals, LLC)

NDC Code: 68025-098-30
Availability: Available
Status: Current
Date of update: September 4, 2025
Update type: Reverified
Therapeutic category: Psychiatry
Initial posting date: July 26, 2023
Contact info: 800-541-4802

Relexxii, Tablet, Extended Release, 63 mg (Vertical Pharmaceuticals, LLC)

NDC Code: 68025-089-30
Availability: Available
Status: Current
Date of update: September 4, 2025
Update type: Reverified
Therapeutic category: Psychiatry
Initial posting date: July 26, 2023
Contact info: 800-541-4802

Relexxii, Tablet, Extended Release, 72 mg (Vertical Pharmaceuticals, LLC)

NDC Code: 68025-084-30
Availability: Available
Status: Current
Date of update: September 4, 2025
Update type: Reverified
Therapeutic category: Psychiatry
Initial posting date: July 26, 2023
Contact info: 800-541-4802

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer